Update: Twist Bioscience Shares Rise After Eli Lilly Drug Discovery Deal

02:11 PM EDT, 09/16/2026 (MT Newswires) -- (Updates with the latest stock price movement in the headline and the first paragraph.) Twist Bioscience (TWST) shares rose 3.5% in Wednesday trading after the company said it agreed to provide antibody characterization data services to Lilly TuneLab, an AI/ML drug discovery platform created by Eli Lilly (LLY). Under the agreement, TuneLab users can order Twist antibody services using preferred protocols to generate data for AI-enabled drug discovery models, including Lilly's AbLab antibody developability prediction model, the company said. Twist said the arrangement will connect experimental data with AI models and support more efficient selection of antibody candidates. Financial terms of the collaboration were not disclosed. Price: 142.96, Change: +4.86, Percent Change: +3.52